{"schema_version":"secwatch.filing_event.v1","accession":"0001104659-26-089293","form_type":"8-K","ticker":"NWBO","cik":"0001072379","company_name":"NORTHWEST BIOTHERAPEUTICS INC","filed_at":"2026-07-31T21:17:23+00:00","discovered_at":"2026-07-31T21:18:00.364669+00:00","generated_at":"2026-07-31T21:18:11.347018+00:00","sec_items":["1.01","2.03"],"event_type":"debt","sentiment":"neutral","materiality_score":0.5,"calibrated_materiality_score":0.5,"confidence":"high","headline":"NW Bio enters $4.9M convertible note financing with Yorkville; also secures $50M standby equity facility","bullets":["$4.9M convertible promissory note, 12-month term, no interest, 5% OID, convertible at discount to market.","Yorkville also acquired warrant to purchase up to $2M shares at $0.205 per share.","Standby equity subscription agreement for up to $50M in common shares, available after note repaid/converted, 24-month term.","Proceeds for general corporate purposes including lead product and in-licensed portfolios.","Prior standby equity subscription agreement cancelled."],"urls":{"canonical":"https://secwatch.observer/filing/0001104659-26-089293","json":"https://secwatch.observer/filing/0001104659-26-089293.json","markdown":"https://secwatch.observer/filing/0001104659-26-089293.md","text":"https://secwatch.observer/filing/0001104659-26-089293.txt","edgar_index":"https://www.sec.gov/Archives/edgar/data/1072379/000110465926089293/0001104659-26-089293-index.htm","edgar_primary_document":"https://www.sec.gov/Archives/edgar/data/1072379/000110465926089293/tm2620800d1_8k.htm"},"model":{"generated_by":"deepseek-v4-flash:cloud@v2","generated_at":"2026-07-31T21:18:11.347018+00:00"},"review":{"review_status":"machine_generated","human_reviewed":false,"corrected":false,"correction_note":null,"correction_timestamp":null,"superseded_by":null,"related_filings":[]},"source_grounded_claims":[],"license":"Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer"}